semaglutide and ovarian cancer Everyone is talking about Ozempic Wegovy for weight loss. But as a gynecologic oncologist what has my attention is what these medications may be doing to risk. Here is what Ovarian cancer in the fatty

A sudden reduction in body weight can also lead to the sagging of the skin

Each SuperBelly packet delivers 1 billion CFU of B

Additional risk factors include: Previous significant weight fluctuations or yo-yo dieting Genetic factors affecting skin quality and collagen production Smoking history, which impairs skin elasticity Inadequate protein intake during weight loss, leading to muscle loss Insufficient resistance exercise to maintain muscle mass Dehydration or poor nutritional status Patients with multiple risk factors should discuss realistic expectations with their GP or diabetes specialist nurse before commencing semaglutide therapy

InThought: After lingering in the BMS pipeline since the infamous $74 billion Celgene acquisition in 2019 and overshadowed by high-profile cell therapies, theyre now nearing center stage with pivotal data imminent

Kaynak: Wall BT, et al